CP
CLBT icon

CenterBook Partners’s Cellebrite CLBT Stock Holding History

CenterBook Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Buy
235,526
+57,020
+32% +$754K 0.17% 142
2026
Q1 		$2.46M Buy
+178,506
New +$2.69M 0.13% 196
2025
Q1 		– Sell
-13,720
Closed -$302K – 490
2024
Q4 		$302K Sell
13,720
-14
-0.1% -$269 0.02% 451
2024
Q3 		$231K Sell
13,734
-283,935
-95% -$4.21M 0.01% 433
2024
Q2 		$3.56M Sell
297,669
-445,172
-60% -$4.97M 0.22% 180
2024
Q1 		$8.23M Buy
+742,841
New +$7.58M 0.57% 35

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

CenterBook Partners's CLBT Position: Q2 2026 in Review

CenterBook Partners increased its Cellebrite (CLBT) stake by 32% in Q2 2026, buying an estimated $754K and bringing the position to 235,526 shares worth $3.44M. The position accounts for 0.17% of the portfolio, ranked #142.

CenterBook Partners first reported a position in CLBT in Q1 2024 and has held it in 6 quarters since. The position peaked at $8.23M in Q1 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • CenterBook Partners held 235,526 shares of Cellebrite worth $3.44M as of Q2 2026.
  • CenterBook Partners bought 57,020 Cellebrite shares in Q2 2026, an estimated $754K.
  • Cellebrite made up 0.17% of CenterBook Partners's portfolio in Q2 2026, its #142 holding.
  • CenterBook Partners first reported a position in Cellebrite in Q1 2024 and has held it in 6 quarters since.
  • CenterBook Partners's Cellebrite position peaked at $8.23M in Q1 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.